138 related articles for article (PubMed ID: 29807145)
21. Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex.
Liu H; Lee ES; Deb Los Reyes A; Zapf JW; Jordan VC
Cancer Res; 2001 May; 61(9):3632-9. PubMed ID: 11325832
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Todorova VK; Kaufmann Y; Luo S; Klimberg VS
Cancer Chemother Pharmacol; 2011 Feb; 67(2):285-91. PubMed ID: 20383709
[TBL] [Abstract][Full Text] [Related]
23. Estradiol and raloxifene induce the proliferation of osteoblasts through G-protein-coupled receptor GPR30.
Noda-Seino H; Sawada K; Hayakawa J; Ohyagi-Hara C; Mabuchi S; Takahashi K; Nishio Y; Sakata M; Kurachi H; Kimura T
J Endocrinol Invest; 2013 Jan; 36(1):21-7. PubMed ID: 22453024
[TBL] [Abstract][Full Text] [Related]
24. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques.
Bethea CL; Mirkes SJ; Su A; Michelson D
Psychoneuroendocrinology; 2002 May; 27(4):431-45. PubMed ID: 11911997
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats.
Chung MT; Cheng PY; Lam KK; Chen SY; Ting YF; Yen MH; Lee YM
Menopause; 2010; 17(1):127-34. PubMed ID: 19745773
[TBL] [Abstract][Full Text] [Related]
26. Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy.
Dixon A; Wells CC; Singh S; Babayan R; Maric C
Am J Nephrol; 2007; 27(2):120-8. PubMed ID: 17308373
[TBL] [Abstract][Full Text] [Related]
27. A new cellular model of pathological TDP-43: The neurotoxicity of stably expressed CTF25 of TDP-43 depends on the proteasome.
Liu Y; Duan W; Guo Y; Li Z; Han H; Zhang S; Yuan P; Li C
Neuroscience; 2014 Dec; 281():88-98. PubMed ID: 25270903
[TBL] [Abstract][Full Text] [Related]
28. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
[TBL] [Abstract][Full Text] [Related]
29. Non-classical estrogen receptors action on human dermal fibroblasts.
Tsui KH; Wang PH; Chen CK; Chen YJ; Chiou SH; Sung YJ; Li HY
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):474-8. PubMed ID: 22212320
[TBL] [Abstract][Full Text] [Related]
30. Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation.
Wang X; Zhou S; Ding X; Ma M; Zhang J; Zhou Y; Wu E; Teng J
Int J Biol Sci; 2015; 11(10):1140-9. PubMed ID: 26327808
[TBL] [Abstract][Full Text] [Related]
31. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
[TBL] [Abstract][Full Text] [Related]
32. 17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage.
Hsieh DJ; Kuo WW; Lai YP; Shibu MA; Shen CY; Pai P; Yeh YL; Lin JY; Viswanadha VP; Huang CY
Cell Physiol Biochem; 2015; 36(1):274-84. PubMed ID: 25967966
[TBL] [Abstract][Full Text] [Related]
33. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Ishihara Y; Itoh K; Ishida A; Yamazaki T
J Steroid Biochem Mol Biol; 2015 Jan; 145():85-93. PubMed ID: 25305410
[TBL] [Abstract][Full Text] [Related]
34. Diallyl Trisulfide Protects Motor Neurons from the Neurotoxic Protein TDP-43 via Activating Lysosomal Degradation and the Antioxidant Response.
Liu C; Leng B; Li Y; Jiang H; Duan W; Guo Y; Li C; Hong K
Neurochem Res; 2018 Dec; 43(12):2304-2312. PubMed ID: 30317421
[TBL] [Abstract][Full Text] [Related]
35. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
[TBL] [Abstract][Full Text] [Related]
36. TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis.
Lanznaster D; Bourgeais J; Bruno C; Hergesheimer RC; Thepault RA; Vourc'h P; Corcia P; Andres CR; Herault O; Blasco H
Cells; 2019 Dec; 9(1):. PubMed ID: 31888078
[TBL] [Abstract][Full Text] [Related]
37. Effects of estradiol benzoate, raloxifen and an ethanolic extract of Cimicifuga racemosa in nonclassical estrogen regulated organs of ovariectomized rats.
Seidlova-Wuttke D; Jarry H; Wuttke W
Planta Med; 2009 Oct; 75(12):1279-85. PubMed ID: 19350480
[TBL] [Abstract][Full Text] [Related]
38. Raloxifene analogue LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway.
Yu J; Eto M; Kozaki K; Akishita M; Okabe T; Ouchi Y
Eur J Pharmacol; 2008 Jul; 589(1-3):32-6. PubMed ID: 18541231
[TBL] [Abstract][Full Text] [Related]
39. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
[TBL] [Abstract][Full Text] [Related]
40. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP.
Cheng CW; Lin MJ; Shen CK
J Neurogenet; 2015; 29(2-3):59-68. PubMed ID: 26219309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
